Opendata, web and dolomites

Vaccinesurvey SIGNED

Monitor population immunity against vaccine preventable diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Vaccinesurvey project word cloud

Explore the words cloud of the Vaccinesurvey project. It provides you a very rough idea of what is the project "Vaccinesurvey" about.

tool    formidable    doctors    situations    vaccination    made    emergency    reactivity    regions    coverage    communication    analytical    proposes    allocate    spatial    co    protein    phones    individual    assay    age    unprecedented    optimization    incentivize    interactive    ordinates    vaccinated    outbreaks    profiles    parallel    agencies    coupled    profile    monitoring    integrates    illnesses    largely    rates    innovative    antibody    effort    records    childhood    district    optimal    small    progress    microarray    mainly    levels    resource    self    poor    read    rate    vaccine    programs    software    performance    donor    population    smart    record    automation    temporal    versus    converts    clinics    preventable    unverified    generating    antigens    determinations    rapid    indirectly    vaccines    experimentally    components    private    pediatrician    children    solution    risk    integrity    questioned    monitor    validate    data    lateral    individuals    additional    connectivity    decrease    power    cross    inferred    utilized    modeling    funds    countries    concerning    immunization    quantify    hospitals    translated    difficult    infection    government    proven    validity    discriminate    diseases    administrative    protection    basis    wireless    portable    simultaneously    infected    certification    healthcare    generate    receiving    flow    indicator    point    collected    capability    multiplex   

Project "Vaccinesurvey" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.vaccinesurveyproject.eu/
 Total cost 1˙053˙000 €
 EC max contribution 1˙053˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2014
 Funding Scheme MSCA-RISE
 Starting year 2015
 Duration (year-month-day) from 2015-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 328˙500.00
2    POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL IT (SIENA) participant 297˙000.00
3    GENIALIS D.O.O SI (LJUBLJANA) participant 220˙500.00
4    UNIVERSITA DEGLI STUDI DI PERUGIA IT (PERUGIA) participant 117˙000.00
5    UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA IT (ROMA) participant 90˙000.00
6    MICROTEST MATRICES LTD UK (LONDON) participant 0.00
7    MINISTERE DE LA SANTE BF (7003 Ouagadougou 03) partner 0.00

Map

 Project objective

In the recent years an unprecedented effort has been made to increase the rates of childhood immunization in resource poor countries. This has translated into an increased number of children receiving vaccines and a parallel decrease in the rate of illnesses from vaccine preventable diseases. However, in some regions it has proven difficult to achieve optimal levels of immunization mainly because of issues concerning communication, management and poor utilization of resources. Recent studies have questioned the validity of available vaccine coverage data and the way they are collected. Currently, both the progress of the vaccination programs and indirectly the level of protection in a population are inferred on the basis of administrative records. This largely unverified information is also utilized as performance indicator to allocate funds from government and donor agencies. Such self-certification practice does not incentivize the optimization of resources while it has been increasingly questioned in terms of its validity and integrity. We propose to develop and validate an innovative technical solution based on an assay system that integrates multiplex capability and analytical performance, to simultaneously quantify antibody levels against the major vaccine components, with both automation and wireless connectivity to produce spatial-temporal co-ordinates of individual determinations. The multiplex capability will facilitate the analysis of cross coverage monitoring while generating reactivity profiles against the different vaccine components to discriminate vaccinated versus infected individuals. Spatial temporal co-ordinates of assay results will be used to generate interactive data sets for modeling changes in the age-specific risk of infection and the risk of outbreaks. The proposed system represents a formidable tool of unprecedented power to monitor the progress of different vaccination programs and experimentally validate record-based coverage data. The consortium proposes to develop an additional implementation of the technology, a low-cost portable microarray solution for healthcare point of testing (i.e. private doctors or pediatrician clinics, small district hospitals, rapid control of real vaccination profile in emergency situations) that converts the protein microarray for the determination of antibody protection against vaccines antigens into a lateral flow protein microarray, which can be coupled with software application for Smart phones to read the results.

 Deliverables

List of deliverables.
Production of second Ethical Review report Documents, reports 2019-11-26 11:58:48
Production of interim disseminating knowledge plan Documents, reports 2019-11-26 11:58:47
Production of initial disseminating knowledge plans Documents, reports 2019-11-26 11:58:47
Nomination of the executive committee and work package leaders Documents, reports 2019-11-26 11:58:46
Production of first Ethical Review report Documents, reports 2019-11-26 11:58:47
Assay slides are produced and passed quality control Other 2019-11-26 11:58:46
Updating the VSO and the database Other 2019-11-26 11:58:49
Presentation of the technology alpha/beta version to stakeholders Documents, reports 2019-11-26 11:58:49
Engage stakeholders and community to collect opinion and feedback Documents, reports 2019-11-26 11:58:49
Mapping of Burkina Faso health care decision-making process Documents, reports 2019-11-26 11:58:47

Take a look to the deliverables list in detail:  detailed list of Vaccinesurvey deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VACCINESURVEY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VACCINESURVEY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More  

NEW MARKETS (2019)

New Market: an exploration into the changing nature of business environments, informal barriers and emerging markets in the post-Soviet region

Read More